DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Herzer K, Welzel TM, Ferenci P. et al.
Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence: Interim results of a multicenter compassionate use program.
Hepatology 2015;
62: 341a-341a
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.